Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2022 | Looking forward to EBMT 2022: get the latest updates in SCT and cellular therapies

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, shares her excitement for the upcoming hybrid EBMT Annual Meeting that will take place on 19-23 March 2022 in Prague, Czech Republic, and virtually as well. This meeting is an opportunity to hear about the latest updates in stem cell transplantation (SCT) and cellular therapies, and to exchange ideas with colleagues. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.

Transcript (edited for clarity)

So the annual meeting of the EBMT that this year is going to happen, starting on the 19th of March, in Prague and it’s going to be hybrid. It’s kind of unique in its setting. So basically, for many, many years, it has been collecting the cutting-edge scientific information regarding stem cell transplantation and other several therapeutic strategies. I think that this meeting is going to be special...

So the annual meeting of the EBMT that this year is going to happen, starting on the 19th of March, in Prague and it’s going to be hybrid. It’s kind of unique in its setting. So basically, for many, many years, it has been collecting the cutting-edge scientific information regarding stem cell transplantation and other several therapeutic strategies. I think that this meeting is going to be special. We have had two virtual meetings in the past, basically because of the COVID-19 pandemic, so I think that everybody would be very happy to meet in a face-to-face format, if possible, and of course, in a hybrid format, with what I would say a really very interesting and exceptional scientific program. Of course, the annual meeting, it’s also a very good environment to have more face-to-face meetings, to meet with colleagues and with friends and hopefully this will be able to be done in Prague. So I really invite all of you to register to the Annual Meeting and if possible, to come to Prague.

Read more...

Disclosures

Honoraria: Takeda, BMS/Celgene, MSD, Janssen, Amgen, Novartis, Gilead Kite, Sanofi, Roche, Alexion
Consultancy: Takeda, BMS/Celgene, Novartis, Janssen, Gilead, Sanofi
Speaker’s Bureau: Takeda
Research support: Takeda, BMS/Celgene